Gram Negative Pneumonia clinical trials

Explore recruiting gram negative pneumonia clinical trials.

Recruiting gram negative pneumonia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Gram Negative Pneumonia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Nebulized Amikacine for Ventilator associated gram negative Pneumonia in ECMO veno-arterial patients: A randomized Pilot Study (NAVAP-ECMO)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Gram Negative Pneumonia trials by city

Gram Negative Pneumonia in Toronto Gram Negative Pneumonia in Vancouver Gram Negative Pneumonia in Montreal Gram Negative Pneumonia in Calgary Gram Negative Pneumonia in Edmonton Gram Negative Pneumonia in Ottawa Gram Negative Pneumonia in Winnipeg Gram Negative Pneumonia in Quebec City Gram Negative Pneumonia in Hamilton Gram Negative Pneumonia in Kitchener Gram Negative Pneumonia in London Gram Negative Pneumonia in Halifax Gram Negative Pneumonia in New York Gram Negative Pneumonia in Los Angeles Gram Negative Pneumonia in Chicago Gram Negative Pneumonia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease